Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers

Deyang Wu1, Xiaowei Liu2, Jingtian Mu1

  • 1State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Biomolecules
|March 25, 2022
PubMed

Insights

Tumor-associated macrophages (TAMs) drive cancer growth and resistance. Targeting TAM-specific proteins offers a novel anti-tumor therapy strategy by reducing TAMs or reprogramming them to fight cancer.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) are key regulators of tumor progression, promoting proliferation, invasion, angiogenesis, stemness, therapeutic resistance, and immune tolerance.
  • Traditional anti-cancer therapies often fall short due to the complex, protein-dependent mechanisms employed by TAMs.
  • TAMs possess unique transcriptional features alongside canonical protein markers, making these proteins attractive therapeutic targets.

Purpose of the Study:

  • To review and summarize current strategies targeting TAM-associated proteins for anti-tumor therapy.
  • To explore novel approaches for reducing TAM numbers or inhibiting their pro-tumoral functions.
  • To highlight the role of TAM metabolism and immunity in reversing the immunosuppressive tumor microenvironment.

Main Methods:

  • Systematic review of current literature on TAM-associated protein targets and their inhibitors.
  • Analysis of recent advances in understanding TAM metabolism and immune functions.
  • Exploitation of strategies to repolarize TAMs towards an anti-tumor phenotype.

Main Results:

  • Identified TAM-associated proteins as promising targets for novel anti-tumor therapies.
  • Demonstrated the efficacy of strategies aimed at reducing TAMs or inhibiting their pro-tumoral functions.
  • Highlighted the potential of reprogramming TAMs to reverse tumor immunosuppression.

Conclusions:

  • Targeting TAM-associated proteins represents a promising avenue for developing effective anti-cancer treatments.
  • Repolarizing TAMs and modulating the tumor microenvironment are crucial for successful anti-tumor immunity.
  • Understanding the crosstalk between TAMs, tumor cells, and immune cells is vital for clinical applications.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
699
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K